CLINICAL

Depression is approximately five times more prevalent in patients with sickle cell disease (SCD) than in the general...

Preliminary data from the ongoing TRANSCEND trial showed that patients with relapsed or refractory diffuse large B-cell lymphoma...

While treatment with CD19-directed chimeric antigen receptor (CAR) T cells has demonstrated impressive response rates of over 80%...

Data from two patients in an ongoing phase I/II clinical trial of LentiGlobin BB305, a gene therapy for...

Impel NeuroPharma announced that the first patient was dosed in the recently-initiated Phase 1 clinical trial of INP104...

Otsuka Pharmaceutical and Lundbeck announce that patient enrollment has been initiated in two global Phase 3 clinical trials...

DRUG

The US Food and Drug Administration (FDA) has approved Merck’s PREVYMIS (letermovir) tablets for oral use and injection...

Sanofi Genzyme and Principia Biopharma have entered into a license agreement to advance the clinical development of PRN2246, an...

Biopharmaceutical company Cerenis Therapeutics is set to acquire Lypro Biosciences assets, a portfolio of drug delivery nanotechnology. The...

Sanofi has signed a licence agreement to develop Principia Biopharma’s Bruton’s tyrosine kinase (BTK) inhibitor (PRN2246), which is...

Quotient Clinical announced that it has signed an agreement with Nuformix Technologies Limited (a wholly owned subsidiary of...

Takeda Pharmaceutical Company Limited and HemoShear Therapeutics announced a partnership to discover and develop novel therapeutics for liver...

MANUFACTURING

Sanofi has signed a licence agreement to develop Principia Biopharma’s Bruton’s tyrosine kinase (BTK) inhibitor (PRN2246), which is...

Recipharm has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines....

CordenPharma has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from...

Merck announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance viral and gene therapy products has completed...

MilliporeSigma today announced the signing of a Memorandum of Understanding (MoU) with Samsung BioLogics for a strategic alliance...

Servier CDMO announces that the company has invested $7.5 million USD in intensified technology included continuous chromatography with simulated...

PROJECTS & WHITEPAPERS

CordenPharma has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from...

Otsuka Pharmaceutical and Lundbeck announce that patient enrollment has been initiated in two global Phase 3 clinical trials...

Flex Pharma announced that, under its open investigational new drug (IND) application, the Company has initiated a Phase...

Ortek Therapeutics announced that the Ortek ECD™ received 510(k) clearance from the U.S. Food and Drug Administration. The ECD...

US-based biopharmaceutical company Pfizer began the construction of a new research and development (R&D) laboratory and office facility...

The presence of residual metal impurities during drug manufacturing has become a major issue in the pharmaceutical industry...